Related references
Note: Only part of the references are listed.1024 In Vivo Efficacy of C12-200 Lipid-Like SiRNA Carriers to Inhibit Hepatic Fibrosis
Carolina Jiménez Calvente et al.
GASTROENTEROLOGY (2015)
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice
Juan E. Puche et al.
HEPATOLOGY (2013)
α11β1 integrin-mediated MMP-13-dependent collagen lattice contraction by fibroblasts: Evidence for integrin-coordinated collagen proteolysis
Malgorzata M. Barczyk et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Stem cell therapies for liver failures and cirrhosis
Zheng Zhang et al.
JOURNAL OF HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Mass-encoded synthetic biomarkers for multiplexed urinary monitoring of disease
Gabriel A. Kwong et al.
NATURE BIOTECHNOLOGY (2013)
Therapy for Fibrotic Diseases: Nearing the Starting Line
Scott L. Friedman et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Recent Developments in Myofibroblast Biology Paradigms for Connective Tissue Remodeling
Boris Hinz et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
A Placebo-Controlled Randomized Trial of Warfarin in Idiopathic Pulmonary Fibrosis
Imre Noth et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Mechanisms of Disease Progression in NASH: New Paradigms
Brittany N. Bohinc et al.
CLINICS IN LIVER DISEASE (2012)
Fibroproliferative Disorders and Their Mechanobiology
Chenyu Huang et al.
CONNECTIVE TISSUE RESEARCH (2012)
Th17 Cells Regulate Liver Fibrosis by Targeting Multiple Cell Types: Many Birds With One Stone
Bin Gao et al.
GASTROENTEROLOGY (2012)
Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
Laurent Castera
GASTROENTEROLOGY (2012)
Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice
Fanli Meng et al.
GASTROENTEROLOGY (2012)
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Juliane S. Troeger et al.
GASTROENTEROLOGY (2012)
MicroRNAs in Liver Disease
Xin Wei Wang et al.
GASTROENTEROLOGY (2012)
NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease
Wing-Kin Syn et al.
GUT (2012)
Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis
Moon Young Kim et al.
HEPATOLOGY (2012)
Accuracy of Real-Time Shear Wave Elastography for Assessing Liver Fibrosis in Chronic Hepatitis C: A Pilot Study
Giovanna Ferraioli et al.
HEPATOLOGY (2012)
Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice
Hacer Sahin et al.
HEPATOLOGY (2012)
Adipose Tissue Invariant NKT Cells Protect against Diet-Induced Obesity and Metabolic Disorder through Regulatory Cytokine Production
Lydia Lynch et al.
IMMUNITY (2012)
The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis
Tatiana Kisseleva et al.
JOURNAL OF HEPATOLOGY (2012)
HSC-specific inhibition of Rho-kinase reduces portal pressure in cirrhotic rats without major systemic effects
Sabine Klein et al.
JOURNAL OF HEPATOLOGY (2012)
New horizons for stem cell therapy in liver disease
Stuart J. Forbes et al.
JOURNAL OF HEPATOLOGY (2012)
Anti-fibrotic therapy: Lost in translation?
Detlef Schuppan et al.
JOURNAL OF HEPATOLOGY (2012)
Clinical evidence for the regression of liver fibrosis
Elizabeth L. Ellis et al.
JOURNAL OF HEPATOLOGY (2012)
Microparticles: Modulators and biomarkers of liver disease
Miroslaw Kornek et al.
JOURNAL OF HEPATOLOGY (2012)
Beneficial effects of candesartan, an angiotensin-blocking agent, on compensated alcoholic liver fibrosis - A randomized open-label controlled study
Moon Young Kim et al.
LIVER INTERNATIONAL (2012)
Treatment of Idiopathic Pulmonary Fibrosis with Losartan: A Pilot Project
Marisa Couluris et al.
LUNG (2012)
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Thomas A. Wynn et al.
NATURE MEDICINE (2012)
Targeting IL-17and TH17 cells in chronic inflammation
Pierre Miossec et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Tatiana Kisseleva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
Prakash Ramachandran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
CXCR4 Inhibitors: Tumor Vasculature and Therapeutic Challenges
Filomena de Nigris et al.
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY (2012)
Integrins as therapeutic targets
Simon L. Goodman et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy
Feng Fang et al.
ARTHRITIS RESEARCH & THERAPY (2012)
The role of chemokines in acute liver injury
Yedidya Saiman et al.
FRONTIERS IN PHYSIOLOGY (2012)
Fibrosis is regulated by Th2 and Th17 responses and by dynamic interactions between fibroblasts and macrophages
Luke Barron et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Role of integrins in fibrosing liver diseases
Eleonora Patsenker et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Therapeutic targets in liver fibrosis
Jonathan A. Fallowfield
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Obesity, diabetes mellitus, and liver fibrosis
Dian J. Chiang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Innate immunity in alcoholic liver disease
Bin Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Suppression of hepatic stellate cell activation by microRNA-29b
Yumiko Sekiya et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Toll-like receptor-4 antagonist eritoran tetrasodium for severe sepsis
Mark Tidswell et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Accelerated and Progressive and Lethal Liver Fibrosis in Mice That Lack Interleukin (IL)-10, IL-12p40, and IL-13Rα2
Margaret M. Mentink-Kane et al.
GASTROENTEROLOGY (2011)
Tissue Transglutaminase Does Not Affect Fibrotic Matrix Stability or Regression of Liver Fibrosis in Mice
Yury Popov et al.
GASTROENTEROLOGY (2011)
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Bin Gao et al.
GASTROENTEROLOGY (2011)
Noninvasive Assessment of Liver Fibrosis
Stella M. Martinez et al.
HEPATOLOGY (2011)
Biomarkers of Liver Fibrosis: What Lies Beneath the Receiver Operating Characteristic Curve?
Indra Neil Guha et al.
HEPATOLOGY (2011)
Pentoxifylline Improves Nonalcoholic Steatohepatitis: A Randomized Placebo-Controlled Trial
Claudia O. Zein et al.
HEPATOLOGY (2011)
Suppression of Innate Immunity (Natural Killer Cell/Interferon-γ) in the Advanced Stages of Liver Fibrosis in Mice
Won-Il Jeong et al.
HEPATOLOGY (2011)
Complementary Vascular and Matrix Regulatory Pathways Underlie the Beneficial Mechanism of Action of Sorafenib in Liver Fibrosis
Dominique Thabut et al.
HEPATOLOGY (2011)
Novel Engineered Targeted Interferon-gamma Blocks Hepatic Fibrogenesis in Mice
Ruchi Bansal et al.
HEPATOLOGY (2011)
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Losartan in the Treatment of Nonalcoholic Steatohepatitis in Humans: A 12-Month Randomized, Prospective, Open-Label Trial
Dawn M. Torres et al.
HEPATOLOGY (2011)
Targeted therapy of liver fibrosis/cirrhosis and its complications
Klaas Poelstra et al.
JOURNAL OF HEPATOLOGY (2011)
A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis
Vlad Ratziu et al.
JOURNAL OF HEPATOLOGY (2011)
Targeted Drug Delivery Using Immunoconjugates: Principles and Applications
Maria Valentina Pasquetto et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Clinical use of CCR5 inhibitors in HIV and beyond
Bruce L. Gilliam et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2011)
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Paul W. Noble et al.
LANCET (2011)
Assessment of atherosclerotic plaque burden with an elastin-specific magnetic resonance contrast agent
Marcus R. Makowski et al.
NATURE MEDICINE (2011)
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Progression of Liver Fibrosis Is Related with Overexpression of the miR-199 and 200 Families
Yoshiki Murakami et al.
PLOS ONE (2011)
Hedgehog Signaling Antagonist Promotes Regression of Both Liver Fibrosis and Hepatocellular Carcinoma in a Murine Model of Primary Liver Cancer
George M. Philips et al.
PLOS ONE (2011)
Protective and pathogenic functions of macrophage subsets
Peter J. Murray et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis
Yury Popov et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Macrophages, Inflammation, and Insulin Resistance
Jerrold M. Olefsky et al.
ANNUAL REVIEW OF PHYSIOLOGY (2010)
PRM-151 (RECOMBINANT HUMAN SERUM AMYLOID P/PENTRAXIN 2) FOR THE TREATMENT OF FIBROSIS
Jeremy S. Duffield et al.
DRUG NEWS & PERSPECTIVES (2010)
Pirfenidone in idiopathic pulmonary fibrosis
H. Taniguchi et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Dead or Alive?
Yury Popov et al.
GASTROENTEROLOGY (2010)
Farglitazar Lacks Antifibrotic Activity in Patients With Chronic Hepatitis C Infection
John McHutchison et al.
GASTROENTEROLOGY (2010)
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo
Joy X. Jiang et al.
GASTROENTEROLOGY (2010)
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C
Robert J. Fontana et al.
GUT (2010)
Signals from dying hepatocytes trigger growth of liver progenitors
Youngmi Jung et al.
GUT (2010)
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease
Julie Parkes et al.
GUT (2010)
Portal Fibroblasts: Underappreciated Mediators of Biliary Fibrosis
Jonathan A. Dranoff et al.
HEPATOLOGY (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
CXC Chemokine Ligand 4 (CXCL4) Is a Platelet-Derived Mediator of Experimental Liver Fibrosis
Mirko Moreno Zaldivar et al.
HEPATOLOGY (2010)
The Fractalkine Receptor CX3CR1 Protects Against Liver Fibrosis by Controlling Differentiation and Survival of Infiltrating Hepatic Monocytes
Karlin Raja Karlmark et al.
HEPATOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Anti-PDGF-B monoclonal antibody reduces liver fibrosis development
Shinji Ogawa et al.
HEPATOLOGY RESEARCH (2010)
Alternative Activation of Macrophages: Mechanism and Functions
Siamon Gordon et al.
IMMUNITY (2010)
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice
Marie-Luise Berres et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Bleomycin and IL-1β-mediated pulmonary fibrosis is IL-17A dependent
Mark S. Wilson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: New targets for the treatment of portal hypertension?
Dominique Thabut et al.
JOURNAL OF HEPATOLOGY (2010)
Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment
Vivian Barry-Hamilton et al.
NATURE MEDICINE (2010)
Evolving challenges in hepatic fibrosis
Scott L. Friedman
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis
Henning W. Zimmermann et al.
PLOS ONE (2010)
Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis
Christian Stockmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Lipid-like materials for low-dose, in vivo gene silencing
Kevin T. Love et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cell Death and Fibrogenesis
Wajahat Mehal et al.
SEMINARS IN LIVER DISEASE (2010)
Chemokines in Liver Inflammation and Fibrosis
Hermann E. Wasmuth et al.
SEMINARS IN LIVER DISEASE (2010)
Macrophages: Master Regulators of Inflammation and Fibrosis
Thomas A. Wynn et al.
SEMINARS IN LIVER DISEASE (2010)
Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C
Jordi Colmenero et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Mechanical Stretch Regulates the Expression of Matrix Metalloproteinase in Rheumatoid Arthritis Fibroblast-Like Synoviocytes
Ping Wang et al.
CONNECTIVE TISSUE RESEARCH (2009)
Regulation of Matrix Synthesis, Remodeling and Accumulation in Glomerulosclerosis
Ambra Pozzi et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans
Hermann E. Wasmuth et al.
GASTROENTEROLOGY (2009)
Hedgehog-Mediated Epithelial-to-Mesenchymal Transition and Fibrogenic Repair in Nonalcoholic Fatty Liver Disease
Wing-Kin Syn et al.
GASTROENTEROLOGY (2009)
Diverse Roles of Invariant Natural Killer T Cells in Liver Injury and Fibrosis Induced by Carbon Tetrachloride
Ogyi Park et al.
HEPATOLOGY (2009)
Pharmacological Inhibition of Integrin αvβ3 Aggravates Experimental Liver Fibrosis and Suppresses Hepatic Angiogenesis
Eleonora Patsenker et al.
HEPATOLOGY (2009)
Targeting Liver Fibrosis: Strategies for Development and Validation of Antifibrotic Therapies
Yury Popov et al.
HEPATOLOGY (2009)
Hepatic Recruitment of the Inflammatory Gr1+ Monocyte Subset Upon Liver Injury Promotes Hepatic Fibrosis
Karlin Raja Karlmark et al.
HEPATOLOGY (2009)
CCR1 and CCR5 promote hepatic fibrosis in mice
Ekihiro Seki et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Adenosine signaling contributes to ethanol-induced fatty liver in mice
Zhongsheng Peng et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathways
Joy X. Jiang et al.
JOURNAL OF HEPATOLOGY (2009)
Pulmonary fibrosis: pathogenesis, etiology and regulation
M. S. Wilson et al.
MUCOSAL IMMUNOLOGY (2009)
Mononuclear cells in liver fibrosis
Fabio Marra et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept An Exploratory, Placebo-controlled Trial
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis
Erwin Gaebele et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Diagnosis and quantitation of fibrosis
Diarmuid S. Manning et al.
GASTROENTEROLOGY (2008)
Magnetic resonance elastography for the noninvasive staging of liver fibrosis
Laurent Huwart et al.
GASTROENTEROLOGY (2008)
Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans
Youngmi Jung et al.
GASTROENTEROLOGY (2008)
Inhibition of integrin αvβ6 on cholangiocytes blocks transforming growth factor-β activation and retards biliary fibrosis progression
Eleonora Patsenker et al.
GASTROENTEROLOGY (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Mechanisms of hepatic fibrogenesis
Scott L. Friedman
GASTROENTEROLOGY (2008)
Prediction of Clinical Outcomes in Primary Biliary Cirrhosis by Serum Enhanced Liver Fibrosis Assay
Marlyn J. Mayo et al.
HEPATOLOGY (2008)
Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans
Alessia Omenetti et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Integrin αvβ6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies
Yury Popov et al.
JOURNAL OF HEPATOLOGY (2008)
Effect of treatment of hepatic histopathology in children and adolescents with autoimmune hepatitis
Alexandre Rodrigues Ferreira et al.
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2008)
Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone
Yasushi Sato et al.
NATURE BIOTECHNOLOGY (2008)
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Adrian M. Di Bisceglie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates
Maria Frank-Kamenetsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Molecular Mechanisms of Lipotoxicity in Nonalcoholic Fatty Liver Disease
Harmeet Malhi et al.
SEMINARS IN LIVER DISEASE (2008)
Antiangiogenic treatment with Sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats
Snia Tugues et al.
HEPATOLOGY (2007)
Role of αvβ6 integrin in acute biliary fibrosis
Bruce Wang et al.
HEPATOLOGY (2007)
TLR4 enhances TGF-β signaling and hepatic fibrosis
Ekihiro Seki et al.
NATURE MEDICINE (2007)
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis
Cristina Ripoll et al.
GASTROENTEROLOGY (2007)
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C
Honjin Huang et al.
HEPATOLOGY (2007)
Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reaction
Michelle M. Richardson et al.
GASTROENTEROLOGY (2007)
Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells
Teresa Gonzalo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-γ1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis
Paul J. Pockros et al.
HEPATOLOGY (2007)
Viusid, a nutritional supplement, in combination with interferon alpha-2b and ribavirin in patients with chronic hepatitis C
Eduardo Vilar Gomez et al.
LIVER INTERNATIONAL (2007)
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Renata Belfort et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mechanical tension and integrin α2β1 regulate fibroblast functions
Beate Eckes et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2006)
Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFκB
Yury Popov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Extracellular matrix, integrins, and mesenchymal cell function in the airways
DJ Fernandes et al.
CURRENT DRUG TARGETS (2006)
Cytokines in atherosclerosis: Pathogenic and regulatory pathways
A Tedgui et al.
PHYSIOLOGICAL REVIEWS (2006)
Progression of fibrosis in hepatitis C with and without schistosomiasis: Correlation with serum markers of fibrosis
SM Kamal et al.
HEPATOLOGY (2006)
Performance of serum marker panels for liver fibrosis in chronic hepatitis C
J Parkes et al.
JOURNAL OF HEPATOLOGY (2006)
Reversal of hepatic fibrosis - Fact or fantasy?
SL Friedman et al.
HEPATOLOGY (2006)
Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term
M Neef et al.
JOURNAL OF HEPATOLOGY (2006)
High-dose acetylcysteine in idiopathic pulmonary fibrosis
M Demedts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection
T Poynard et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis
RG Wells
JOURNAL OF CLINICAL GASTROENTEROLOGY (2005)
The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse
A Canbay et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Spontaneous recovery from micronodular cirrhosis: Evidence for incomplete resolution associated with matrix cross-linking
R Issa et al.
GASTROENTEROLOGY (2004)
Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect
DR Nelson et al.
HEPATOLOGY (2003)
Clinical observation of salvianolic acid B in treatment of liver fibrosis in chronic hepatitis B
P Liu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2002)
Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
T Poynard et al.
GASTROENTEROLOGY (2002)
Decreasing fibrogenesis: an immunohistochemical study of paired liver biopsies following lamivudine therapy for chronic hepatitis B
YO Kweon et al.
JOURNAL OF HEPATOLOGY (2001)
Interleukin-13 induces tissue fibrosis by selectively stimulating and activating transforming growth factor β1
CG Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Matrix as a modulator of hepatic fibrogenesis
D Schuppan et al.
SEMINARS IN LIVER DISEASE (2001)
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis
C Corpechot et al.
HEPATOLOGY (2000)
Share Paper
